These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15253942)

  • 1. Glucocorticoid treatment and cardiovascular disease.
    Ng MK; Celermajer DS
    Heart; 2004 Aug; 90(8):829-30. PubMed ID: 15253942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.
    Wei L; MacDonald TM; Walker BR
    Ann Intern Med; 2004 Nov; 141(10):764-70. PubMed ID: 15545676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality?
    Gonzalez-Gay MA
    Arthritis Rheum; 2007 Mar; 57(2):191-2. PubMed ID: 17330291
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.
    Maradit Kremers H; Reinalda MS; Crowson CS; Davis JM; Hunder GG; Gabriel SE
    Arthritis Rheum; 2007 Mar; 57(2):279-86. PubMed ID: 17330277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.
    Souverein PC; Berard A; Van Staa TP; Cooper C; Egberts AC; Leufkens HG; Walker BR
    Heart; 2004 Aug; 90(8):859-65. PubMed ID: 15253953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
    Davis JM; Maradit Kremers H; Crowson CS; Nicola PJ; Ballman KV; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Mar; 56(3):820-30. PubMed ID: 17330254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids and cardiovascular risk factors.
    Strohmayer EA; Krakoff LR
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):409-17, ix. PubMed ID: 21565675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.
    Fardet L; Fève B
    Drugs; 2014 Oct; 74(15):1731-45. PubMed ID: 25204470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries for patients. Glucocorticoid medications and the risk for cardiovascular disease.
    Ann Intern Med; 2004 Nov; 141(10):I58. PubMed ID: 15545672
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoids and cardiovascular disease.
    Walker BR
    Eur J Endocrinol; 2007 Nov; 157(5):545-59. PubMed ID: 17984234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic and cardiovascular adverse events of systemic glucocorticoid therapy].
    Fardet L
    Rev Med Interne; 2013 May; 34(5):303-9. PubMed ID: 23313327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased cardiovascular risk due to glucocorticoids: how strong is the evidence?].
    Vedder D; Nurmohamed MT
    Ned Tijdschr Geneeskd; 2021 Apr; 165():. PubMed ID: 33914434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased risk of for cardiovascular events from high doses].
    Kreutzkamp B
    Med Monatsschr Pharm; 2005 Nov; 28(11):410-1. PubMed ID: 16309026
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.
    Da Silva JA; Jacobs JW; Kirwan JR; Boers M; Saag KG; Inês LB; de Koning EJ; Buttgereit F; Cutolo M; Capell H; Rau R; Bijlsma JW
    Ann Rheum Dis; 2006 Mar; 65(3):285-93. PubMed ID: 16107513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-induced diabetes in rheumatologic patients.
    Angelopoulos TP; Tentolouris NK; Bertsias GK; Boumpas DT
    Clin Exp Rheumatol; 2014; 32(1):126-30. PubMed ID: 24143933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular accidents due to long term corticotherapy].
    de Vahia JL
    Maroc Med; 1969; 49(527):488-92. PubMed ID: 5398370
    [No Abstract]   [Full Text] [Related]  

  • 17. A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass index.
    Zhang YP; Gong Y; Zeng QY; Hou ZD; Xiao ZY
    BMJ Open; 2015 Jun; 5(6):e006957. PubMed ID: 26041488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
    Petersons CJ; Mangelsdorf BL; Thompson CH; Burt MG
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Feb; 76(2):201-207. PubMed ID: 28088991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Major side effects of systemic glucocorticoid].
    Kudo C
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():317-21. PubMed ID: 25831775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.